Bipera 2 mg Tablet Philippines - English - FDA (Food And Drug Administration)

bipera 2 mg tablet

innogen pharmaceuticals, inc.; importer: n/a; distributor: multicare pharmaceuticals phils. inc. - biperiden hydrochloride - tablet - 2 mg

Salmed 50 mcg/250 mcg Dry Powder for Inhalation in Capsule Philippines - English - FDA (Food And Drug Administration)

salmed 50 mcg/250 mcg dry powder for inhalation in capsule

innogen pharmaceuticals, inc.; importer: n/a; distributor: multicare pharmaceuticals phils. inc. - salmeterol (as xinafoate) , fluticasone propionate - dry powder for inhalation in capsule - 50 mcg/250 mcg

Salmed 50 mcg/500 mcg Dry Powder for Inhalation in Capsule Philippines - English - FDA (Food And Drug Administration)

salmed 50 mcg/500 mcg dry powder for inhalation in capsule

innogen pharmaceuticals, inc; importer: n/a; distributor: multicare pharmaceuticals phils. inc. - salmeterol (as xinafoate) , fluticasone propionate - dry powder for inhalation in capsule - 50 mcg/500 mcg

None 500 mg/10 mg Capsule Philippines - English - FDA (Food And Drug Administration)

none 500 mg/10 mg capsule

innogen pharmaceuticals, inc.; importer: n/a; distributor: rose pharmacy, incorporated - ascorbic acid , zinc - capsule - 500 mg/10 mg

Calm-Pro 50 mg/160 mg (5%/16% w/w) per g Cream Cream Philippines - English - FDA (Food And Drug Administration)

calm-pro 50 mg/160 mg (5%/16% w/w) per g cream cream

innogen pharmaceuticals, inc.; importer: n/a; distributor: n/a - calamine , zinc oxide - cream - 50 mg/160 mg (5%/16% w/w) per g cream

Calmit-Z 50 mg/160 mg per gram (5%/16% w/w) Cream Philippines - English - FDA (Food And Drug Administration)

calmit-z 50 mg/160 mg per gram (5%/16% w/w) cream

solvang pharmaceuticals, inc.; importer: n/a; distributor: innogen pharmaceuticals, inc. - calamine , zinc oxide - cream - 50 mg/160 mg per gram (5%/16% w/w)

LABETALOL HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

labetalol hydrochloride tablet, film coated

innogenix, inc. - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride tablets, usp are indicated in the management of hypertension. labetalol hydrochloride tablets, usp may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics. labetalol hydrochloride is contraindicated in bronchial asthma, overt cardiac failure, greater-than-first-degree heart block, cardiogenic shock, severe bradycardia, other conditions associated with severe and prolonged hypotension, and in patients with a history of hypersensitivity to any component of the product ( see   warnings ). beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including asthma.

HALOPERIDOL tablet United States - English - NLM (National Library of Medicine)

haloperidol tablet

innogenix, inc. - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol tablets, usp are indicated for use in the management of manifestations of psychotic disorders. haloperidol tablets, usp are indicated for the control of tics and vocal utterances of tourette’s disorder in children and adults. haloperidol tablets, usp are effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). haloperidol tablets, usp are also effective in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. haloperidol tablets, usp should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics. haloperidol tablets, usp are contraindicated in severe toxic central nervous system depression or

HALOPERIDOL tablet United States - English - NLM (National Library of Medicine)

haloperidol tablet

major pharmaceuticals - haloperidol (unii: j6292f8l3d) (haloperidol - unii:j6292f8l3d) - haloperidol tablets, usp are indicated for use in the management of manifestations of psychotic disorders. haloperidol tablets, usp are indicated for the control of tics and vocal utterances of tourette’s disorder in children and adults. haloperidol tablets, usp are effective for the treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). haloperidol tablets, usp are also effective in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. haloperidol tablets, usp should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics. haloperidol tablets, usp are contraindicated in severe toxic central nervous system depression or

METOLAZONE tablet United States - English - NLM (National Library of Medicine)

metolazone tablet

major pharmaceuticals - metolazone (unii: tz7v40x7vx) (metolazone - unii:tz7v40x7vx) - metolazone tablets, usp, are indicated for the treatment of salt and water retention including: · edema accompanying congestive heart failure; · edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. metolazone tablets, usp, are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. mykrox tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. a dose titration is necessary if mykrox tablets are to be substituted for metolazone tablets, usp, in the treatment of hypertension. see package circular for mykrox tablets. usage in pregnancy the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia.